Pubpeer读者来信:FigCheck软件查询到图片替换和重复使用

文摘   2024-09-14 16:44   江西  

 提示欢迎点击上方「Pubpeer」↑关注我们!

编者按


最新、最快、最真实的科研匿名评价论文报道;关注高校院所科研生态,欢迎提供新闻线索。联系邮箱:Pubpeer@qq.com

近日,有网友爆料称,贵州中医药大学第一附属医院的一个研究团队在多篇学术论文中涉嫌学术不端行为,其中包括图片的故意替换和重复使用。

据悉,该团队的研究论文《Gehua Jiecheng Decoction Inhibits Diethylnitrosamine-Induced Hepatocellular Carcinoma in Mice by Improving Tumor Immunosuppression Microenvironment》于2020年发表在《Frontiers in Pharmacology》杂志上。该研究主要探讨了葛花解酲汤对小鼠肝癌的抑制作用及其通过改善肿瘤免疫抑制微环境来实现的机制。

然而,有网友发现,该论文中的图2E和图2F存在数据图片被替换的情况,特别是蓝色圈出的数据部分。此外,图3B中的两张图片也被指出存在异常相似的情况。这些发现引发了对该研究真实性和可靠性的质疑。

除了上述论文外,该团队的其他几篇论文也受到了关注。其中包括《Tryptanthrin Protects Mice against Dextran Sulfate Sodium-Induced Colitis through Inhibition of TNF-α/NF-κB and IL-6/STAT3 Pathways》等,这些论文分别发表在不同的学术期刊上。

值得注意的是,该团队的多名成员,包括杨柳、唐东昕、王飞清和李燕菊等,在这些论文中担任了重要角色。目前,这些论文在学术网站Pubpeer上已被标注并受到广泛质疑。

对此,网友们呼吁相关期刊和机构应尽快展开调查,核实这些论文的真实性和可靠性,并追究相关责任人的责任。同时,也提醒广大科研工作者要坚守学术道德,遵循科研规范,共同维护学术界的纯洁性和公信力。

Dear editors and colleagues,

Figures from "Gehua Jiecheng Decoction Inhibits Diethylnitrosamine-Induced Hepatocellular Carcinoma in Mice by Improving Tumor Immunosuppression Microenvironment" (Cheng et al 2020; doi: 10.3389/fphar.2020.00809). 

The authors provided a replacement image for different conditions in the Figure 2E and Figure 2F, if I understand the figure legends correctly. The second row of Figure 2E and the first row of Figure 2F were from the same data source. The fourth row of Figure 2E and the third row of Figure 2F were from the same data source. Surprisingly, the data in the blue cycle (the data indicated in the right corners of the fourth of Figure 2E and the third of Figure 2F) has been deliberate changed! They should provide the all the original data and figures in this article and explain why they re-used the images! 

In addition, two images from Figure 3B were found unexpected similarly by the FigCheck software.

It may be determined the findings reported in the article were unreliable. Please double check and reply me ASAP.

Please check out the original data and the review process for articles published by these teams in your journals.

 PS:

Please look into the following three articles, which have been seriously queried by Actinopolyspora biskrensis and Penicillium citreoviride and highlighted in Pubpeer web.

1. Tryptanthrin Protects Mice against Dextran Sulfate Sodium-Induced Colitis through Inhibition of TNF-α/NF-κB and IL-6/STAT3 Pathways. Molecules. 2018 May 2;23(5):1062. doi: 10.3390/molecules23051062.

https://pubpeer.com/publications/0451DE02FD6BC912932D664630B3B8#1

2. Inhibitory effects of Chanling Gao on the proliferation and liver metastasis of transplanted colorectal cancer in nude mice. PLoS One. 2019 Feb 21;14(2):e0201504. doi: 10.1371/journal.pone.0201504.

https://pubpeer.com/publications/1E59E95EFCB751DFA5CB0E89C5459B#

3. QiShenYiQi Pills, a Compound Chinese Medicine, Ameliorates Doxorubicin-Induced Myocardial Structure Damage and Cardiac Dysfunction in Rats. Evidence-based Complementary and Alternative Medicine. 2013:2013:480597. doi: 10.1155/2013/480597.

https://pubpeer.com/publications/AD0A7C2F90A29E3B9E133AFEFF2CBA#2

 I have reported suspected fake images from this team, including Yang Liu, Dong-xin Tang, Fei-qing Wang and Yan-ju Li. In that publication (MiR-34a Regulates Nasopharyngeal Carcinoma Radiosensitivity by Targeting SIRT1" (Liu et al 2020; doi.org/10.1177/1533033820940424), The first author Yang Liu (Department of Clinical Laboratory, The First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine; National & Guizhou Joint Engineering Laboratory for Cell Engineering and Biomedicine Technique, Guizhou Medical University) and the co-corresponding authors Feiqing Wang (Department of Clinical Laboratory, The First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine) and Yanju Li (Department of Hematology, Affiliated Hospital of Guizhou Medical University) should be held responsible for all these!

 

From THE SAME RESEARCH TEAM at the same organization (The First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine) Dong-xin Tang, who was the corresponding author in the above article, should be warned by editors and readers!

It turns out ALL the publications from this team therefore should be investigated by the editors!

 

Best regards,

Shozo


来源:公众号pubpeer原创,文章涉及作者姓名都为音译名字;转载贴子请注明出处,若没注明pubpeer公众号出处,构成侵权。


推荐文章:

Elisabeth Bik这样回复本公众号pubpeer

零容忍!2024年7月19日科技部通报: 国家重点研发计划4个抄袭问题、1个项目评审请托问题

2024年中科院预警期刊名单正式发布!入选理由引用操纵和论文工厂、中国作者占比畸高!

2024年国家自然科学基金委不端行为案件处理结果通报(第一批次)

学术打假者的胜利?兰州大学杰青董广辉名誉侵权案一审败诉

山东科研诚信管理办法来了!这些行为将被严惩

处理331人!48位通报批评,永久取消2人评委资格!国家基金委发布2023年度报告

取消评优评先资格2年...取消项目申报、科技奖励、科技人才等资格2年!重庆通报1则科研失信行为处理结果

去年国外撤回大量中国学者论文,教育部:开展高校撤稿论文自查

2023年12月21日科技部发布科研行为规范指引,严明科研底线和规范

大连理工大学马院Nature子刊撰文:466所中国医科大学研究诚信统计报告

国家基金委通报2023年第二批不端行为案件处理结果,共24项

多高校提彻底清理学术不端论文存量:挂名现象等从2018年起自查

国家自然基金委通报今年首批八起学术不端案件,七起涉“医”,中南大学湘雅医学院,南方医科大学在列!

长安大学一教师论文剽窃多次被通报:党内严重警告、撤销教授资格

国自然学术不端警示动画-1:抄袭剽窃:“抄人”现形记

2022年查处的不端行为案件处理结果通报(第三批次)

西安交大多位医生被通报批评,涉伪造论文、项目申请书抄袭剽窃

济宁市第一人民医院10月被撤6篇论文:编造研究过程、代写代投

内蒙古医科大李春阳论文代写代投署名不实,被撤销国自然项目

国自然基金委通报多起学术不端:12人被处理,追回逾百万经费

国家卫健委通报16起医学科研诚信案,含北京协和医院等

极大关注!该研究团队被通报35篇文章,已经被撤稿18篇文章

500余名医务人员被处罚!多名被取消医师职称、博士学位

2022年3月18日,科技部通报54起学术不端论文调查处理通报

12家医院43人上榜!开年大整治!国家卫健委通报医学论文造假名单

2021年8月份以来,卫健委已经公布了12批的国内医学机构的科研诚信案件调查处理结果。

国家卫健委10月15日通报,部分机构医学科研诚信案件调查处理结果

国家卫健委曝光10起医学论文造假、科研失信案件 严惩涉事人员

国家卫健委官网:论文造假,17名医生被通报

零容忍!中科院对7类学术论著署名行为说“不”


声明:转载此文是出于传递更多信息之目的。若有来源标注错误或侵犯了您的合法权益,请作者持权属证明与本网联系,我们将及时更正、删除,谢谢


Pubpeer专注科研工作者。关注请长按上方二维码。投稿、合作、转载授权事宜请联系本号,回复2024微信ID:pubpeer992 或邮箱:Pubpeer@qq.com


Pubpeer
最新、最快、最真实的科研匿名评价论文报道;关注科研生态,欢迎提供新闻线索。联系邮箱:Pubpeer@qq.com
 最新文章